retatrutide expanded access program Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide has not been approved

Lifestyle changes are essential

Get Moving Light activity, such as walking or stretching, helps activate your GI system and relieve nausea symptoms

Some people use it daily while adjusting to GLP-1, while others use it more strategically during workouts, hot weather, or days when eating is especially low

This third hormone may help boost metabolism and fat burning even more than drugs like Zepbound

The goal is to maintain that crucial 2C to 8C temperature range

The cardiovascular benefits of weekly injected GLP-1 receptor agonists have been proven in SUSTAIN-6 (Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes), REWIND (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) and The Harmony outcomes trials